Podcasts about Precision

Let's take a breath and examine the exquisite contradictions of the modern Left. These are the people warning that your carbon footprint will murder the planet in a slow apocalyptic bake. The same ones who unleashed a virus, weaponized the panic, and turned it into the perfect mechanism for election interference and pharmaceutical windfalls. Precision timing, wasn't it? ICE just pulled 700,000 violent criminals off American streets. Actual predators with rap sheets longer than most congressional careers. Democrats' response? Defund the agency immediately. Because apparently the real public safety threat is the people removing the threats. They came within striking distance of nominating an actual Nazi for Senate in Maine. Not hyperbole, not online slang — the real article. Yet we're still lectured daily about which side endangers democracy. In Los Angeles, the mayor's race looks like it was decided with the same creative bookkeeping that defines their national playbook. The frontrunner presided over burning streets and an exploding homelessness crisis she swore she would fix. Now Spencer Pratt claims he's holding audio receipts that could expose the entire operation. Democrats treat clean elections the way vampires treat sunlight — they'll do anything to keep it away. Cheating isn't a tactic for them. It's the default setting. And the Trump contortions remain comedy gold. The man who struck Iran's nuclear ambitions, collapsed their economy, and left them economically gasping is now portrayed as some kind of reckless warmonger desperate to “pay them off” to end a conflict that isn't even officially a war. The mental yoga required to sell that story should qualify for the Olympics. They shrug at systemic welfare fraud that drains billions, but the sight of a self-made trillionaire sends them into convulsions. A man who generated that wealth by building products people voluntarily buy — no coercion, no subsidies, no mandates. That offends their sensibilities more than endless dependency schemes. So instead of acknowledging human achievement, they pivot straight to outrage theater. The world's first trillionaire deserves fireworks. They're delivering eulogies and pitchforks. This and plenty more on today's show. So here are the questions worth asking out loud: How does a political faction simultaneously fear productive billionaires and coddle career criminals? When did preventing fair elections become their most consistent skill set? And if innovation and voluntary exchange trigger them more than chaos and dependency, what exactly are they conserving — because it clearly isn't progress? Lines are open. Let's hear it.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

What if the experience you think makes you an outsider in the design industry is actually your greatest advantage? In this episode of Designed for the Creative Mind, Michelle Lynne sits down with interior designer Katie Rainey to discuss her journey from Doctor of Physical Therapy to owner of a thriving interior design firm specializing in waterfront and lifestyle-driven homes. Katies design philosophy is that beauty and function are necessities, not luxuries.  With a Doctorate in Physical Therapy and a background in human movement, she crafts spaces that are both beautiful and intuitively designed for real life.  She partners with busy families and professionals seeking solace in nature - whether by the water in Annapolis or in the mountains of New Hampshire - guiding them through the intricacies of a renovation or a new build.  With deep construction knowledge, she collaborates closely with builders and architects to ensure seamless execution from concept to completion.  As part of a military family, Katie has lived across the U.S. and in Europe.  She draws inspiration for her designs from this global design perspective, having lived in diverse landscapes. Katie shares how she initially hid her medical background, believing it had little relevance to design, only to discover that her expertise in movement, ergonomics, and human behavior became one of her strongest differentiators. From designing custom solutions that improve clients' daily lives to building a business rooted in confidence, process, and professionalism, Katie offers valuable lessons for designers at every stage of business. The conversation also explores networking, pricing, client communication, boundaries, and the mindset shifts that helped Katie transition from treating design as a passion to running it as a profitable business. Whether you're transitioning from another career, struggling to communicate your value, or looking for encouragement to own your unique story, this episode is packed with practical wisdom and inspiration. In This Episode, We Discuss: Katie's transition from physical therapy to interior design Why your previous career can become your biggest business advantage Using ergonomics and human movement to create more functional homes How Katie found her unique positioning in the design industry The mindset shift from hobbyist to business owner Learning to separate emotion from sales conversations The "Pass the Salt" approach to discussing money with clients Why clear processes create better client experiences Educating clients through deliverables and expectations The importance of boundaries and scope management Networking strategies that helped Katie build a business in a brand-new market How confidence and consistency lead to stronger business growth Balancing motherhood, business ownership, and personal fulfillment Key Takeaways Your Past Experience Is Part of Your Expertise Katie spent years downplaying her background as a physical therapist before realizing it gave her a unique perspective that directly benefits her clients. The skills, knowledge, and experiences from previous careers often become the very thing that sets designers apart. Design Is More Than Making Things Beautiful A successful design must function for the people who live in it. Katie's understanding of ergonomics and movement helps her create spaces that support her clients' lifestyles while remaining beautiful. Confidence Comes from Process One of Katie's biggest business breakthroughs came from developing a clear process and communicating it effectively. When clients understand what to expect, they feel more confident moving forward. Networking Doesn't Have to Be Complicated From introducing herself to architects to striking up conversations at the gym and ice rink, Katie demonstrates that meaningful business relationships often start with a simple conversation. Business Growth Requires Personal Growth Success isn't just about improving your design skills. It's about developing confidence, setting boundaries, understanding your value, and learning how to lead clients through decisions. Memorable Quotes "Own your background. Whatever you did before design, there's something there that makes you a better designer." "If it looks beautiful but doesn't function for you, what's the point?" "You're not trying to convince clients to hire you. You're guiding them as the expert." "We are a for-profit company, not a non-profit." "We're most memorable in person, not behind our computer." "Whoever is going to hire me isn't going to hire you because I'm not you and you're not me." Connect with Katie Rainey Website: katieraineydesign.com Instagram: @katieraineydesign Facebook: Katie Rainey Design Connect with Michelle Lynne If you enjoyed this episode, be sure to subscribe, leave a review, and share it with a fellow interior designer who could benefit from today's conversation. For coaching, mentorship, and business resources for interior designers, visit our website at thedesignbakehouse.com.  Loved This Episode? Leave a review and share this episode with another designer who needs the reminder that their unique background isn't something to hide—it's something to build on.  

This week we talk about: Zoho Community Spaces: Building and Managing Online Communities Zoho CRM: Record Sharing for Activities Modules Zoho Forms: Spotlight Forms Our Code Share, Read, Tip and Question of the Week Read the show notes: https://zenatta.com/episode-410/    ⚖️ Avalara AvaTax for Zoho CRM ⚖️ Accurate Tax. Zero Guesswork.

After 5 long years of waiting Gustav Iden FINALLY joins us on The Triathlon Hour. This was a podcast we thought might never happen because Gustav almost never does these long format, sit down podcasts. Gustav is the 2022 Ironman Kona World Champion, 2019 & 2021 Ironman 70.3 World Champion, PTO Canadian Open champion and went on a 4 year undefeated streak from 2019-2022 in long course triathlon. We ask him all the training, racing & life questions we've been waiting to and that we know YOU want to hear. This podcast was worth the wait.  Try NOMIO for yourself. Discount code - TTH15 (for 15% off). In Europe - https://drinknomio.com In America - go to thefeed.com and search “Nomio” In Australia - go to aidstation.com.au and search “Nomio” Precision Fuel & Hydration: Use the code TTH15 to get 15% off your first order with Precision at their website. We would LOVE if you could tell Precision you heard about them from The Triathlon Hour in their "how did you hear about us?" question when purchasing - it helps support the podcast. Pillar Performance: Use the discount code TTH15 to get 15% off your first order with Pillar Performance at their website or if you're in North America use the TTH15 discount code at The Feed.  

In this episode, we take you inside the world of elite bike fitting with Ivan O'Gorman, a world-renowned fitter based in Niwot, Colorado who works with top professional triathletes and cyclists. We break down why a professional fit is one of the highest ROI investments you can make—impacting comfort, power, aerodynamics, and injury prevention. Ivan shares his approach to assessing athletes, the technology behind modern fitting, and real-world examples of how small positional changes drive big performance gains. Whether you're new to the sport or chasing your next PR, this episode will help you understand what it takes to ride like the pros.Vespa Power Endurance helps you tap into steady, clean energy—so you stay strong, focused, and in the zone longer. Vespa isn't fuel—it's a metabolic catalyst that helps your body use more fat and spare precious glycogen.Whether you're training for your next PR or racing long, Vespa helps you go the distance with sustained energy and faster recovery.Home of Vespa Power Products | Optimizing Your Fat MetabolismUse discount code 303endurance20Grit2Greatness Links & Calls to Action Website: Grit2Greatness Endurance Coaching Facebook: @grit2greatnessendurance Instagram: @grit2greatness_endurance Ambassador Application: https://forms.gle/mQjPbyzjAmmBhM6m9 Become a Team Member: Getting Started with Grit2Greatness - Google Forms Podcast Subscription: Grit2Greatness Endurance - Podcast - Apple Podcasts

Elliott Lorenz took an unusual path into consumer lending, moving from applied mathematics and high-frequency trading into the business of pricing credit risk. Today he is the CEO and co-founder of Edge Focus, a technology-enabled private credit firm that sits between consumer lending platforms and the institutional investors who want to deploy capital into the asset class. In this episode, Elliott explains how the firm's credit engine works, why speed is its biggest edge, and how he reads the recent wave of criticism aimed at private credit.What We CoveredFrom engineering and applied math to high-frequency tradingWhat Michael Lewis's Flash Boys got right and wrong about HFTSpotting an edge in LendingClub's public loan dataTurning a data-science hobby into Edge FocusThe Origin credit engine and how it makes decisionsExpanding a lender's credit box with an orthogonal view of creditModeling with a single month of payment historyUpdating a credit model within a dayThe Lens portfolio analytics toolWhere alpha comes from beyond the underwriting modelFraud and asset liability mismatch in private creditBuilding the EDGEX ABS shelf and partnering with FortressProving ML models are free from biasWhere consumer lending goes over the next few yearsKey TakeawaysEdge Focus competes less on having a single better model and more on combining technology, capital, and platform relationships in one package, which Elliott calls the firm's "big unlock."The firm can incorporate even a single month of payment history into its models and push an update within a day, letting it react to macro shifts faster than firms that wait 12 to 24 months for data.Most of the recent private credit criticism falls into two buckets, fraud and asset liability mismatch, and Elliott sees the fraud cases as largely idiosyncratic and the redemption problems as a function of investors misjudging illiquid assets.Because Edge Focus invests its own capital alongside partners rather than acting as a pure technology vendor, its incentives are tied directly to loan performance.About Elliott LorenzElliott Lorenz is the CEO and co-founder of Edge Focus, a technology-enabled private credit firm focused on consumer lending. He trained as an engineer and applied mathematician, earned a master's in finance from Princeton, and spent several years in high-frequency trading before bringing those modeling techniques into consumer credit in 2013.Connect with Fintech One-on-One:Tweet me @PeterRentonConnect with me on LinkedInFind previous Fintech One-on-One episodes

Why are more people becoming afraid of vaccines than the diseases vaccines were created to prevent? The answer is not simply a lack of information. In many ways, vaccines have become victims of their own success.For decades, widespread vaccination helped push diseases like measles, polio, pertussis, and smallpox out of everyday life. Many of us no longer live with the visible fear of these infections, their complications, or the way they can destabilize families, communities, and healthcare systems.But when the disease feels distant, the vaccine can start to feel like the bigger threat.That shift is now changing public health.Rather than assuming vaccine hesitancy is only about ignorance or defiance, we need to look more carefully at:• why people can become more suspicious of vaccines when they no longer see the diseases vaccines helped control• How misinformation, fear, personal experience, politics, history, and social media can shape health decisions• Why highly educated people can still be vulnerable to vaccine misinformation• how confusing a side effect, adverse event, or normal immune response with a true allergy can create long-term fear• Why egg allergy is no longer the vaccine barrier many people still believe it is• And how declining vaccination rates can allow diseases like measles and pertussis to reemergeVaccine education has to move beyond simply telling people what to do. We need clearer, more compassionate conversations that acknowledge fear while helping people separate facts from fiction.In this upcoming episode, I'm joined by Dr. Joyce Yu, associate professor of pediatrics and director of the Food Allergy Program at Columbia University Irving Medical Center.Together, we explore:What is driving the rise of vaccine hesitancyWhy vaccine-preventable diseases can return when communities let their guard downHow allergists help patients understand whether a vaccine reaction is truly an allergyAnd why rebuilding trust requires listening, clarity, and evidence-based conversationIf you or someone you love has ever felt uncertain, afraid, or confused about vaccines, allergic reactions, side effects, or conflicting health information, this conversation offers a grounded look at how fear spreads, how misinformation takes hold, and why protecting public health depends on rebuilding trust.Guest BioDr. Joyce Yu is an associate professor of pediatrics and director of the Food Allergy Program at Columbia University Irving Medical Center. She is an allergy and immunology specialist with clinical and scientific expertise in food allergy, immunology, vaccine-related concerns, and immune system function. Dr. Yu received her medical education at the Icahn School of Medicine at Mount Sinai, completed her residency at Northwestern/Lurie Children's Hospital, and completed her fellowship in Allergy and Immunology at Mount Sinai. Her postdoctoral work focused on toll-like receptor signaling and memory B cell development, mechanisms that are closely connected to how the immune system develops lasting protection. She is a fellow of both the American College of Allergy, Asthma & Immunology and the American Academy of Allergy, Asthma & Immunology. She is also a former president of the New York Allergy and Asthma Society and has held leadership roles within the Clinical Immunology Society. Connect with Dr. Yu on LinkedIn.About Your HostHosted by Dr. Deepa Grandon, MD, MBA, a triple board-certified physician with over 23 years of experience working as a Physician Consultant for influential organizations worldwide. Dr. Grandon is the founder of Transformational Life Consulting (TLC) and an outspoken faith-based leader in evidence-based lifestyle medicine.Disclaimer ​​TLC is presenting this podcast as a form of information sharing only. It is not medical advice or intended to replace the judgment of a licensed physician. TLC is not responsible for any claims related to procedures, professionals, products, or methods discussed in the podcast, and it does not approve or endorse any products, professionals, services, or methods that might be referenced.Work With Me Learn More About My Soon-to-Launch Telemedicine PlatformExciting news. My virtual medical platform is launching soon! If you're looking for personalized, evidence-based care in allergy, immunology, and lifestyle medicine, stay tuned.Visit drdeepa-tlc.org and click on “Learn More” to join the waitlist and be the first to receive updates about services, membership options, and launch details.Precision care. Personalized guidance. Wherever you are.DevotionalsWant to receive a devotional every week from Dr. Deepa? Devotionals are dedicated to providing you with a moment of reflection, inspiration, and spiritual growth each week, delivered right to your inbox. Visit drdeepa-tlc.org to subscribe for free.Trauma CoursesReady to deepen your understanding of trauma and kick-start your healing journey? Explore a range of online and onsite courses designed to equip you with practical and affordable tools. From counselors, ministry leaders, and educators to couples, parents, and individuals seeking help for themselves, there's a powerful course for everyone. Browse all the courses now to start your journey.

Please visit answersincme.com/CNW860 to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Stephen V. Liu, MD and Amber Fake. In this activity, an expert in non–small-cell lung cancer (NSCLC) discusses the evolving patient-centered management of HER2-mutant NSCLC, focusing on the use of HER2-targeted TKIs. Upon completion of this activity, participants should be better able to: Describe how HER2-targeted TKIs may address the clinical needs for diverse patient populations with HER2-mutant NSCLC; Implement evidence-based molecular profiling to identify HER2 alterations in NSCLC; Evaluate the clinical evidence of current and emerging HER2-targeted treatments; and Integrate shared decision-making strategies to align preferences for patients with HER2-mutant NSCLC.

Please visit answersincme.com/CNW860 to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Stephen V. Liu, MD and Amber Fake. In this activity, an expert in non–small-cell lung cancer (NSCLC) discusses the evolving patient-centered management of HER2-mutant NSCLC, focusing on the use of HER2-targeted TKIs. Upon completion of this activity, participants should be better able to: Describe how HER2-targeted TKIs may address the clinical needs for diverse patient populations with HER2-mutant NSCLC; Implement evidence-based molecular profiling to identify HER2 alterations in NSCLC; Evaluate the clinical evidence of current and emerging HER2-targeted treatments; and Integrate shared decision-making strategies to align preferences for patients with HER2-mutant NSCLC.

Are we witnessing the collapse of the government's 10-year NHS plan, or are we on the brink of a healthcare revolution? Live from the NHS ConfedExpo 2026 in Manchester, former health ministers Steve Brine and James Bethel sit down to analyse a seismic period for health and politics. Following the shocking resignation of Wes Streeting and the appointment of James Murray as Secretary of State, we ask: who is steering the ship, and could an Andy Burnham administration be on the horizon?We also dive into incredible healthcare breakthroughs: the world's first AI-designed vaccine passing human trials at the University of Cambridge, and game-changing precision therapies doubling advanced pancreatic cancer survival rates.Plus, special guests Richard Sloggett (Future Health Research) and Lee-Ann Farrell (J&J) join the pod to discuss social care levies, NHS structural changes, and the reality of innovation on the frontline.

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. The landscape of these industries is one of constant evolution, characterized by scientific advancements, strategic mergers, and regulatory maneuvers that shape the future of healthcare. In a significant scientific breakthrough, Merck & Co. and Gilead Sciences have made strides in HIV treatment with the development of a weekly pill. This innovative regimen combines Merck's islatravir with Gilead's lenacapavir, showing promise in two phase 3 trials. If approved, this long-acting oral therapy could revolutionize HIV care by offering a more convenient dosing schedule, potentially improving patient adherence and outcomes substantially. This novel regimen signifies progress towards simplifying HIV treatments with once-weekly dosing. Meanwhile, in the oncology sector, Gilead's Trodelvy faced challenges when combined with Merck's Keytruda as a first-line treatment for PD-L1-high non-small cell lung cancer. The phase 3 EVOKE-03 trial was terminated, shifting attention to competitors like AstraZeneca and Daiichi Sankyo, who continue to advance their own therapies in this area. In a strategic move to bolster its position in lung cancer treatment, GlaxoSmithKline (GSK) is acquiring Nuvalent for $10.6 billion, aiming to secure near-approval cancer therapies capable of challenging market leaders like Roche and Pfizer. This acquisition underscores the focus on targeted cancer therapies that increase treatment efficacy by honing in on specific genetic markers. Nuvalent's innovative pipeline of small molecule inhibitors targets drug resistance and mutations in cancer treatment—a strategic addition to GSK's portfolio aimed at enhancing its position amidst rapid advancements and intense competition in oncology. In diabetes and obesity management, Eli Lilly is advancing with its new oral GLP-1 receptor agonist, Foundayo (orforglipron), which has shown competitive efficacy over oral semaglutide. Analysts see Lilly's progress as strengthening its leadership in the growing obesity drug market. Similarly, AstraZeneca is making progress with its own GLP-1 candidate, elecoglipron, as phase 2 data sets the stage for pivotal studies. Promising clinical trial data from Eli Lilly's retatrutide for obesity-related conditions and AstraZeneca's elecoglipron suggest a strengthening pipeline for GLP-1 receptor agonists known for their dual effects on weight management and glycemic control. On the diagnostics front, Roche reaffirms its €600 million investment in Germany amid industry retrenchments by companies like Eli Lilly and Boehringer Ingelheim. However, Roche remains cautious about future risks due to shifting economic conditions. The financial dynamics within biotech are also noteworthy. Parabilis Medicines is planning a potentially record-setting IPO following Kailera Therapeutics' successful public offering earlier this year. These trends indicate strong investor confidence and an influx of funding towards innovative cancer therapies. Meanwhile, CeQur's $100 million Series E funding round aims at accelerating insulin patch delivery systems' commercial growth—highlighting ongoing innovation in diabetes management solutions. Regulatory updates reveal AstraZeneca facing reprimands from the UK marketing watchdog due to repeated breaches related to LinkedIn activities—an ongoing challenge in pharmaceutical marketing compliance. The integration of digital health solutions continues apace as ixlayer partners with Vertex Pharmaceuticals to launch a digital acute pain management platform. This initiative aims at improving patient care by reducing reliance on opioid-based treatments. These developments paint a picture of an industry where scientific innovations, regulatory hurdles, and technological advancements intersect to shape future therapeutic landscapes. Precision oncology is another area witnessing substantial growth. The landscape also sees notable activity in rare disease therapeutics. Johnson & Johnson's Talvey has gained acceptance in Scotland for treating relapsed multiple myeloma using bispecific antibody technology—a trend toward leveraging immune system targeting technologies to enhance cancer treatment efficacy. Moreover, Zai Lab's Tivdak received approval from China's NMPA for cervical cancer treatment based on Phase 3 data, highlighting the rise of antibody-drug conjugates (ADCs) as potent oncology therapies due to their targeted delivery mechanisms. On the research collaboration front, AlzeCure Pharma's partnership with Eli Lilly focuses on Alzheimer's disease research through Alzstatin ACD680—a small molecule targeting neurodegenerative pathways—a testament to the collaborative efforts needed to tackle complex diseases like Alzheimer's. However, challenges persist as Bial discontinued its GCase activator program after failing Phase 2b trials for Parkinson's patients with GBA1 variants—a stark reminder of the high-risk nature inherent in drug development despite initial promise. These myriad developments underscore a vibrant period within pharmaceutical and biotech sectors where scientific advancements rapidly translate into actionable therapies promising substantial improvements in patient care by addressing unmet medical needs globally.Support the show

Hosted by MJGibson live at MJBizCon 2025, this episode—sponsored by SHOPLINE in association with ICBC—features Grant Schuster and Jim Pivaldi of AccelerantManufacturing on how Swiss-engineered automation is reshaping cannabis cone production. From laser-engraved customization and 200M+ monthly output to a production-as-a-service model that redefines scalability, the conversation cuts straight to what's changing in cannabis manufacturing and why it matters.WEBSITE: https://cannatechtoday.com/Make sure to follow our other social media platforms to stay up-to-date on all things Cannabis & Tech Today.https://twitter.com/cannatechtodayhttps://www.facebook.com/CannaTechTodayhttps://www.instagram.com/cannatechtoday

The gravitational two-body problem has been fundamental to physics since Newton's time. With the advent of gravitational wave astronomy and the anticipated third generation of gravitational wave detectors in the 2030s, there is an increasing need for high-precision predictions from Einstein's theory of gravity regarding the encounters of black holes and neutron stars in our universe. Fascinatingly, perturbative quantum field theory methods developed for high-precision predictions of elementary particle scattering at the LHC have proven remarkably efficient for this classical physics problem. This unexpected connection has led to inspiring synergies between collider and gravitational wave physics. In my talk, I will present our approach using a worldline quantum field theory inspired by string theory, which has emerged as the most efficient tool for quantifying the scattering of spinning black holes. We have achieved highest-precision perturbative results for the scattering angle, radiated energy, and recoil of such black hole encounters at the fifth order in Newton's gravitational coupling G. Our four-loop calculations have revealed a new class of mathematical functions related to Calabi-Yau manifolds, previously studied only in mathematics and string theory compactifications, appearing for the first time in a physical context: The radiated energy in gravitational waves at NNNNLO perturbation theory.

"You never get a second shot at quality—do it right the first time." Episode Summary In this episode, we sit down with Gage Moulding, the Vice President of HSM Ammunition, to talk about all things ammo. We dig deep into the science and consistency required to build truly reliable ammunition, the importance of family culture in a manufacturing business, and how real-world feedback from shooters shapes the products HSM produces. We also explore how the industry reacts to supply chain challenges, changing regulations, and technological advances. Whether you're a competitive shooter, a hunter, or a casual range enthusiast, this episode delivers the kind of insider perspective you've always wanted on what it takes to put the highest quality rounds in your magazine. Call to Action  1. Subscribe and leave us a comment on Apple or Spotify 2. Follow us on all of our social media: Instagram Youtube 3. Grab some cool TGE merch 4. Ask us anything at AskMikeandKeith@gmail.com 5. Be sure to support the sponsors of the show. They're a big part of making the show possible. Show Sponsors HSM Ammunition: Proudly made in the USA with tight quality control. Check them out at hsmammunition.com or your local sporting goods store. OnSight Firearms Training (OFT): Real-world defensive shooting instruction by pros who walk the walk. Find a course that meets your needs at OFTLLC.us Key Takeaways Modern factory ammo can rival handloads in consistency and performance due to advanced quality control systems. HSM's company culture is built around family values and customer service, ensuring your concerns are addressed by real experts. Longevity among employees (loaders with 17+ years at HSM) brings unmatched institutional knowledge and consistent manufacturing processes. Supply chain disruptions (especially for powder and primers) remain the industry's biggest challenge. Preparedness (safety stock) is essential. Real-world feedback from hunters, competitors, and law enforcement directly influences new product development at HSM. Ammunition price increases reflect rising costs across the board, not higher profits for manufacturers. Not all calibers are created equal—find out why .44 Magnum is underrated and the myth behind "just fill it to the top" when reloading. Guest Information Name: Gage Moulding Position: Vice President, HSM Ammunition Background: Former Army Officer, extensive experience in manufacturing and distribution, passionate about hunting, fishing, and shooting sports. Keywords ammunition manufacturing, HSM Ammunition, ammo quality control, factory ammo vs handloads, competitive shooting, hunting ammo, family business, American-made ammo, ammo supply chain, powder shortage, shooting sports, reloading myths, gun industry trends, best rifle ammo, premium projectiles, .44 Magnum, subsonic ammunition

Send us Fan MailIn this episode of Small-Cap Spotlight, Ning Ding, Chairman and CEO of ZJK Industrial, joins WTR's Tim Gerdeman, Co-Founder and Chief Marketing Officer and equity analyst Eric Goldstein to unpack the company's record 2025 results, its expanding role in the AI infrastructure supply chain, and a multi-year plan to scale production globally — including a new Vietnam facility and a planned U.S. R&D and testing center.ZJK Industrial (NASDAQ: ZJK) is a Shenzhen-based precision metal parts manufacturer with one of the most technically demanding portfolios in global manufacturing — supplying AI infrastructure, liquid cooling for high-performance computing, electric vehicles, aerospace, medical devices, and advanced electronics.

Architect and engineer Noémie Aureau founded Atelier No'Au after nearly eight years at Renzo Piano Building Workshop in Paris. Her work brings together technical precision, environmental awareness and a sensitive reading of place.In this short episode of Com d'Archi, she reflects on the origins of her practice and explains how engineering and architecture can work together to shape meaningful projects. For her, constraints are not obstacles but opportunities to create elegant, resilient and lasting architecture. The conversation also focuses on one of Atelier No'Au's first major projects: the extension of a holiday resort on the Brittany coast. Designed through an off-site construction approach, the project combines timber structures, prefabricated components and careful integration within an exceptional natural landscape. Through this example, Noémie Aureau discusses design for assembly, low-carbon construction and the possibilities offered by industrialised timber building systems developed with SYbois, a key partner in both the project and this podcast.A concise and inspiring episode about architecture, innovation and the search for balance between technology, nature and human experience.Audio consulting: NyreTeaser image © Com d'Archi PodcastSYbois, the low-carbon timber-frame wall and façade construction solution. The SYbois concept is the art of designing a wall around its opening: the window system it integrates.___If you like the podcast do not hesitate:. to subscribe so you don't miss the next episodes,. to leave us stars and a comment :-),. to follow us on Instagram @comdarchipodcast to find beautiful images, always chosen with care, so as to enrich your view on the subject.Have a wonderful week! Hébergé par Acast. Visitez acast.com/privacy pour plus d'informations.

Talia Cohen Solal, CEO and Co-Founder of NeuroKaire, is focused on improving patient outcomes of those with depression by predicting the most effective antidepressant for each individual. The NeuroKaire platform personalizes psychiatric treatment by creating neurons from a patient's blood sample to model their brain and test drug responses, pointing the way to an effective treatment, avoiding prolonged trial-and-error. This is a significant advancement over existing pharmacogenomic tests, which primarily provide information on drug metabolism rather than drug efficacy. This technology is also being applied to other conditions like ADHD, schizophrenia, bipolar disorder, and epilepsy.   Talia explains, "At NeuroKaire, we are dedicated to improving patient outcomes in psychiatry and neurology. To do that, we've developed a platform to predict which antidepressant is best for each patient and are expanding out to other disease indications to achieve that mission."   "Basically, around 2006, Yamanaka and his colleagues discovered that you could take any cell in the body and turn it back into a stem cell. And that changed everything for the field. So what we can do now is we can take a blood sample, turn it back into a stem cell, and then turn it into whatever cell type we'd like. And our mission is to help people with brain disorders and psychiatric disorders. And so we turn those stem cells into neurons. And now we have a model of the patient's brain. Now we have neurons from the patient's brain and a little ecosystem mimicking a patient's brain. And there we can actually see what's going wrong in the connectivity, what's changed in those patients, and what drugs are going to have the best outcome to reverse those changes." #NeuroKaire #PrecisionPsychiatry #MentalHealth #Antidepressants #BrightKaire #PersonalizedMedicine #PGx #Neuroscience #HealthcareInnovation neurokaire.com Listen to the podcast here

Talia Cohen Solal, CEO and Co-Founder of NeuroKaire, is focused on improving patient outcomes of those with depression by predicting the most effective antidepressant for each individual. The NeuroKaire platform personalizes psychiatric treatment by creating neurons from a patient's blood sample to model their brain and test drug responses, pointing the way to an effective treatment, avoiding prolonged trial-and-error. This is a significant advancement over existing pharmacogenomic tests, which primarily provide information on drug metabolism rather than drug efficacy. This technology is also being applied to other conditions like ADHD, schizophrenia, bipolar disorder, and epilepsy.   Talia explains, "At NeuroKaire, we are dedicated to improving patient outcomes in psychiatry and neurology. To do that, we've developed a platform to predict which antidepressant is best for each patient and are expanding out to other disease indications to achieve that mission."   "Basically, around 2006, Yamanaka and his colleagues discovered that you could take any cell in the body and turn it back into a stem cell. And that changed everything for the field. So what we can do now is we can take a blood sample, turn it back into a stem cell, and then turn it into whatever cell type we'd like. And our mission is to help people with brain disorders and psychiatric disorders. And so we turn those stem cells into neurons. And now we have a model of the patient's brain. Now we have neurons from the patient's brain and a little ecosystem mimicking a patient's brain. And there we can actually see what's going wrong in the connectivity, what's changed in those patients, and what drugs are going to have the best outcome to reverse those changes." #NeuroKaire #PrecisionPsychiatry #MentalHealth #Antidepressants #BrightKaire #PersonalizedMedicine #PGx #Neuroscience #HealthcareInnovation neurokaire.com Download the transcript here

What if the invisible signals surrounding us every day were quietly affecting our health, our food, our livestock, and even future generations?In this eye-opening episode, David DeHaas sits down with Daniel Stachowski of Essential Energy to explore the growing impact of electromagnetic fields (EMFs), cell towers, wireless technology, precision agriculture, and data-driven farming practices.From brain fog and fertility concerns to declining food quality, livestock health issues, and the rise of smart farming technologies, this conversation uncovers how modern electromagnetic pollution may be influencing every aspect of life—from human biology to agriculture.If you're concerned about your family's health, food quality, farming practices, environmental sustainability, or the future of agriculture, this is an episode you won't want to miss.Are EMFs silently impacting your health, fertility, food supply, and livestock production?In this fascinating discussion, David DeHaas welcomes Daniel Stachowski, founder of Essential Energy, to examine the growing concerns surrounding electromagnetic field (EMF) exposure and its potential effects on people, animals, crops, and the environment.Daniel shares his personal journey from working with major technology companies like Microsoft and Amazon to researching the biological effects of electromagnetic radiation after health challenges within his own family led him to investigate root causes of illness.Together they discuss:• EMFs and brain fog• Cell towers and wireless radiation• Fertility concerns and reproductive health• Livestock productivity and animal wellness• Precision agriculture and smart farming• Food nutrient density and quality• Data centers and electromagnetic pollution• Regenerative agriculture• Farm privacy concerns• The future of food production• Environmental health and sustainability• How EMFs may affect plants, pollinators, and ecosystemsThe conversation also explores emerging research on nutrient density in food produced on EMF-safe farms, potential impacts on dairy production and livestock fertility, and what farmers and consumers can do to create healthier environments.Whether you're a farmer, rancher, health-conscious consumer, parent, or simply curious about the relationship between technology and biology, this episode provides a thought-provoking perspective on one of the most overlooked topics in modern health and agriculture.ABOUT THE GUEST:Daniel StachowskiFounder, Essential EnergyWebsite:www.EssentialEnergy.usABOUT THE HOST:Living Waters Wellness CenterDavid DeHaas855 S Curtis RdBoise, ID 83705Office: (208) 378-9911Connect with Living Waters Wellness Center to learn more about holistic health, detoxification, regenerative wellness, nutrition, and natural healing strategies.Thank you for listening to the Whole Body Detox Show with David DeHaas.If you found value in this episode, please like, subscribe, and share it with friends, family members, farmers, ranchers, and anyone interested in improving their health and understanding the impact of modern technology on our environment and food supply.For more expert interviews and natural health solutions, visit:www.livingwaterscleanse.comUntil next time, remember: your health is your greatest asset, and understanding the environment around you is a powerful step toward protecting it.Support the showReady for your healing journey?Visit our website: www.LivingWatersCleanse.com Or give us a call at: (208) 378-9911Stem Cell Activation Patches:www.StemCellPatch.netGet your Supplements and Natural Body Products Here:www.livingwaterscleanse.com/supplementsQI-Shield EMF Devices:Protect your whole home or office with a touric shield from EMF's. 1. QI Shield Covers 16'x16'2. QI Home Covers 50' x 50'3. QI Max Covers 250'x250'Click on link and enter Livingwaters in discount code section during checkoutMagnesium Soaks:Follow us on our socials: Living Waters Wellness CenterBitChute: www.bitchute.com/livingwaterswellnessRumble: www.rumble.com/living...

As privacy regulations tighten across the healthcare sector, traditional touch-based tracking models are distorting the true impact of cross-channel marketing campaigns. In this episode, we explore how advanced Marketing Mix Modeling (MMM) and privacy-first identity tracking can reveal your actual marketing channel performance without sacrificing compliance. Learn how to transition from platform vanity metrics to mathematically verified, incremental business growth. Check us out at: mmm-online.com   Follow us:  YouTube: @MMM-online TikTok: @MMMnews Instagram: @MMMnewsonline Twitter/X: @MMMnews LinkedIn: MM+M   To read more of the most timely, balanced and original reporting in medical marketing, subscribe here. Music: “Deep Reflection” by DP and Triple Scoop Music. Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.

********** This week we talk about: Zoho: Announcements Hub Zoho Analytics: May 2026 Feature Updates Zoho Inventory: April & May 2026 Updates Our Code Share, Read, Tip and Question of the Week Read the show notes: https://zenatta.com/episode-409/    ⚖️ Avalara AvaTax for Zoho CRM ⚖️ Accurate Tax. Zero Guesswork.

Dr. Pedro Barata and Dr. Bridget Keenan discuss the innovative bioengineering allowing clinicians to target historically "immune-cold" tumors, the logistical evolution of bringing bispecific therapies safely into outpatient community clinics, and the complex future of predictive biomarkers and resistance mechanisms. LINK TO FULL TRANSCRIPT

He was the man who turned sparse, muscular prose into a blueprint for the 20th century. But before the Nobel Prize, the big-game hunting, and the larger-than-life legend, there was just a young man writing in the cafés of Paris.In this episode of History Ignited, we strip away the myth to find the man behind the typewriter. We explore how Ernest Hemingway's experiences in the Great War and the Lost Generation shaped his relentless pursuit of "the true sentence." From the sun-drenched rings of Spanish bullfights to the quiet complexities of his most iconic short stories, we trace the literary evolution of one of America's most polarizing figures. Tune in as we examine the man who didn't just write about life—he lived it to its breaking point.Send us Fan MailAbout History Ignited: History Ignited is the award-winning kids and family history podcast inspired by Billy Joel's We Didn't Start the Fire. Each short episode explores the real stories behind the people, events, inventions, and cultural moments that shaped the world from the 1950s through the 1980s. Winner of the 2025 Webby People's Voice Award for Best Kids & Family Podcast.

Lucy Charles-Barclay, the Ironman World Champion, multiple Ironman 70.3 World Champion and all-round superstar joins us to give you as many of her training secrets as you've ever heard before. Lucy said before the podcast that whatever I asked, she would give us all the details about - so we took advantage of that! Lucy also gives us some great behind the scenes insight that she'd never talked about before with her racing & life. This was an in-depth chat with the triathlete everyone loves.  Try NOMIO for yourself. Discount code - TTH15 (for 15% off). In Europe - https://drinknomio.com In America - go to thefeed.com and search “Nomio” In Australia - go to aidstation.com.au and search “Nomio” Precision Fuel & Hydration: Use the code TTH26 to get 15% off your first order with Precision at Precision Fuel & Hydration Pillar Performance: Use the discount code TTH15 to get 15% off your first order with Pillar Performance at their website or if you're in North America use the TTH15 discount code at The Feed. Nerd Belts Discount code - TTH26 (for 15% off) Click here to buy yourself a Nerd Belt

What if trauma is more than a psychological experience? In this episode, I sit down with Dr. Aimie Apigian, a Preventive and Addiction Medicine Physician and founder of Trauma Healing Accelerated™, to explore how trauma becomes stored in the body and influences the nervous system, metabolism, immune function, and overall health. Together, we challenge the conventional view of trauma and examine why unresolved survival responses can contribute to chronic symptoms, fatigue, dysregulation, and disease. We discuss the differences between stress and trauma, the body's survival adaptations, the five patterns of stored trauma, and the critical role of the autonomic nervous system in recovery. Dr. Aimie shares her Biology of Trauma® framework, explaining how healing goes beyond mindset and requires creating safety within the body to restore resilience, regulation, and lasting health. If you've ever wondered why some patterns seem impossible to change, why chronic symptoms persist despite doing everything "right," or why healing often feels incomplete, this conversation may completely transform the way you think about trauma, health, and recovery.   Key takeaways: Trauma is not limited to psychological impacts but involves complex biological adaptations that affect the entire body system. Stress and trauma are distinct, with trauma representing an overwhelming threat that triggers a different survival response. Unresolved trauma can lead to chronic health conditions, including autoimmunity and fatigue, highlighting the need for integrative healing methods. Healing from trauma requires creating an environment of safety before addressing deeper emotional and physiological issues. Effective trauma therapy should incorporate mind work, body somatic work, and biology for comprehensive healing.   More About Dr. Aimee Apigian: Dr. Aimie Apigian is a double board-certified physician in Preventive and Addiction Medicine, with advanced training in biochemistry, public health, and functional medicine. She is the national bestselling author of The Biology of Trauma (foreword by Gabor Maté), featured on the USA TODAY Best-Selling Booklist and recipient of multiple book awards. She is known for making trauma healing both precise and deeply human, bridging functional medicine, attachment science, and trauma therapy to show how the body stores survival patterns and what it specifically needs to heal. Through her Biology of Trauma® framework, she integrates somatic work, parts work, and targeted biology to identify where the system is blocked and restore its capacity for healing through a structured, measurable sequence. Dr. Aimie is the founder of Trauma Healing Accelerated™ and host of the Biology of Trauma® Podcast, where she trains individuals and practitioners worldwide to move beyond insight into real, lasting change. Website Instagram Connect with me! Website Instagram Facebook YouTube

Welcome to The Turf Zone podcast. This episode features the article “Advancing Precision Weed Management in Turfgrass Systems with Machine Vision-Guided Targeted Spraying” Written by Brooke Heikkila – Graduate Research Assistant Navdeep Godara – Assistant Professor of Turfgrass & Forage Weed Science, Department of Crop and Soil Sciences, North Carolina State University and Pawel Petelewicz – Assistant Professor of Turfgrass Weed Science, University of Florida, Institute of Food and Agricultural Sciences, Agronomy Department Turfgrass managers are facing increasing weed challenges due to evolving regulatory framework and growing incidence of herbicide-resistant weeds. The release of the first turfgrass-specific commercial machine vision-guided sprayer (ALBA, Ecorobotix Inc.) enables automated and localized herbicide applications in turf. Although often referred to as “spot spraying” in marketing materials, “targeted spraying” is a more accurate description as it distinguishes this system from manual spot treatments and other existing precision weed management approaches. Such targeted application systems have already been successfully deployed in other crops using platforms such as the John Deere See and Spray, Agritech America WEED-IT, Verdant Robotics Sharp Shooter, Ecorobotix ARA. Using See and Spray technology, comparable weed control was observed between the broadcast and targeted spraying methods, but the targeted spraying reduced the treated acreage by up to two-thirds. In turfgrass, this technology not only offers significant herbicide savings but also opens the door for practitioners to combat herbicide-resistant weeds by incorporating alternative chemistries, including nonselective herbicides or herbicide tank mixtures combining multiple modes-of-action which are not typically feasible in broadcast applications. Overall, spot spraying is not a new concept, as many turfgrass managers already employ it to control weed escapes following broadcast herbicide applications or where selective chemistries are not an option. Manual spot spraying involves individuals walking the golf course or other turfgrass areas with a sprayer loaded with herbicide to make localized applications directly to weeds. Traditional spot spraying is labor-intensive, time-consuming, and requires applicators to accurately identify weeds, necessitating additional training and expertise. It ultimately increases application costs and is also prone to human error, often resulting in overapplication and missed weeds. However, targeted spraying systems such as ALBA, utilize artificial intelligence combined with machine vision to detect problematic weeds within turfgrass canopy in real-time to apply herbicides only to those small areas where individual weeds are present. ALBA is a tractor pull-behind unit that can operate at speeds up to 4.5 miles per hour and uses an enclosure to block ambient light and to create consistent lighting conditions to continuously scan the turfgrass canopy with its cameras to detect weeds. When a weed is spotted, an individual nozzle – one out of 108 – activates to directly target the weed with a 1.2 × 1.2-inch spray resolution per nozzle. As targeted application systems continue to advance and competing platforms emerge, it is critical to understand how to effectively integrate and leverage these sprayers within turfgrass weed management programs. Several preliminary field experiments using ALBA and its ARA-based predecessor research platform were conducted by the NC State Turfgrass Weed Science Program and the UF/IFAS Turfgrass Weed Science Program to understand the applications of this technology. Preliminary studies showed that machine-vision guided targeted spraying substantially reduces herbicide usage and treated acreage while maintaining weed control efficacy, offering both economic and environmental benefits while targeting wide variety of problematic weeds with high accuracy. Reduction in Herbicide Volume Used – In a study focused on controlling false-green kyllinga in bermudagrass fairways, machine vision-guided targeted spraying with ALBA reduced herbicide spray volume by 77% compared to broadcast treatments. False green kyllinga cover was 17% at the experimental sites during study initiation, triggering significant savings due to the weed-specific, localized targeted treatments compared to broadcast herbicide applications. Broadcast applications of standard kyllinga control products typically cost around $190 to $240 per acre, but targeted treatment can lower the cost by more than $145 per acre even when dealing with moderate level of weed infestation (~15% weed cover). Similarly, in another ongoing study, when annual bluegrass weed cover was 10% in bermudagrass fairways, targeted applications achieved a 66% reduction in herbicide spray volume compared to conventional broadcast treatments. Sulfonylurea herbicides for postemergence control of annual bluegrass cost around $140 to $185 per acre and targeted spraying can reduce the cost by at least $92 per acre when weed cover is 10% or less. Practitioners can expect greater savings at turfgrass sites with lower weed infestations, which are typical of intensively managed surfaces and when applying expensive herbicides such as PoaCure or organic herbicides during winter dormancy of warm-season turfgrasses. Targeted application system was also evaluated for control of broadleaf weeds, dallisgrass, smooth crabgrass, and tropical signalgrass in studies conducted independently or in collaboration between Mississippi State University, NCSU, Virginia Tech and UF IFAS, and observed a 53% to 95% reduction in spray volume. In all the aforementioned cases, weed control levels achieved with targeted spraying were no different from broadcast applications. Thus, these studies demonstrate that, across various problematic weed species, this novel application system can substantially reduce the herbicide volume required, lowering costs without compromising weed control efficacy. Lower Treated Acreage – During broadcast herbicide applications, substantial areas without weeds are often treated unnecessarily. Targeted applications can reduce the treated acreage, enabling practitioners to use herbicides such as MSMA, which are currently restricted to spot treatments on less than 25% of the total golf course acreage per year. Targeted spraying systems are particularly useful for herbicides with limited or no residual activity, as it allows localized treatments to weed instead of broadcast applications to turfgrass. Targeted spraying for false-green kyllinga control (17% weed cover) in bermudagrass fairways resulted in 85% reduction in treated acreage compared to broadcast spraying. In a similar study, an 80% reduction in treated acreage was found when only treating annual bluegrass in dormant bermudagrass at 10% weed cover. A study conducted by UF/IFAS Turfgrass Weed Science Program using circular, non-overlapping targets of varying patch sizes (4-10 cm diameter) to simulate random different weed densities and dispersions within the 1-20%, 21-40%, and 41-60% coverage, indicated total spray deposition of approximately 40%, 64%, and 74%, respectively. This corresponded to estimated herbicide savings of 60%, 36%, and 26%. Spray deposition increased with rising weed pressure, while the non-sprayed area, directly reflecting herbicide savings declined accordingly. These results confirm that variation in herbicide savings with targeted applications is driven primarily by weed density, with dispersion playing a secondary role, exerting stronger effects at low weed densities but negligible influence at higher densities. The reduction in treated acreage can potentially diminish the environmental impact of herbicides by minimizing overall pesticide load released into the environment, limiting off-target movement, reducing the risk of groundwater contamination, and lowering the risk of human exposure associated with pesticide applications. Targeted approaches permit treatment to a limited portion of turf, enabling the effective use of chemistries with area-use limitations. Effective reduction in area treated with targeted spraying will become increasingly important as new regulations come into effect, particularly in the context of upcoming Endangered Species Act-imposed changes. Therefore, research projects funded by the Turfgrass Council of North Carolina will focus on investigating the agronomic and environmental benefits of targeted application systems for managing problematic weed species. Alternative Herbicide Options for Resistance Management – Targeted spraying also enables selectivity at the sprayer level rather than relying only on selectivity of the herbicide used. This potentially allows turf managers to use nonselective herbicides that were previously not an option for broadcast treatment due to severe injury to actively growing turfgrasses. Broad spectrum herbicides like glyphosate, glufosinate, or flumioxazin are highly effective against a wide variety of weeds, but practitioners often wait for turfgrass to go dormant before spraying nonselective herbicides, while in some geographies, such as Florida, achieving full dormancy is not even possible. However, with this new technology, practitioners will have the option to incorporate nonselective herbicides year-round with minimal collateral damage to turfgrass. Glyphosate (Roundup Pro Concentrate) applied via broadcast application at 12 fluid ounces per acre rate reduced bermudagrass green cover significantly, but targeted spraying had similar level of green cover as nontreated plots as documented in our recent study. Likewise, glufosinate applied at 41 fluid ounces per acre (as Finale XL T&O) reduced bermudagrass cover drastically after broadcast application but had minimal effect on turfgrass after targeted spraying. Targeted spraying technology also allows use of novel admixtures that are not currently being used during regular turfgrass maintenance. Rotating or tank mixing herbicide from different modes of action are crucial for sustainable turfgrass management, as selection pressure for herbicide resistance continues to increase. For instance, practitioners can use tank mixtures of herbicides like pyridate + sulfentrazone or bentazon + halosulfuron + sulfentrazone for targeted spraying without compromising efficacy on false-green kyllinga. These novel admixtures contain multiple modes of action in a single application that could reduce selection pressure and combat herbicide-resistant kyllinga. Similar admixtures should be explored for the management of other herbicide-resistant or difficult-to-control weeds. Limitations – Like with any new technologies, there are limitations to consider when adopting a machine vision-guided sprayer. Currently, only one commercial unit (ALBA by Ecorobotix Inc.) is available, providing managers with a single option for this turfgrass-specific targeted spraying technology. Additional machine vision-guided sprayers need to be developed specifically for turfgrass systems, as interest in these technologies among turfgrass managers continues to grow and the needs across different turfgrass industry segments will vary. The cost of the equipment and the annual model subscription will be a major barrier for many turfgrass managers. Offering incentives, such as reduced subscription fees for the first few years, could help increase adoption of this technology. Alternatively, with ALBA being an example of a high-end solution maximizing performance and system sophistication, other developers may consider trade-offs to reduce equipment production and maintenance costs to improve accessibility. Although ALBA seems to demonstrate high detection accuracy on key problematic weeds, further research is needed to understand its year-round performance, considering changes in visual characteristics of weeds and turfgrass across growth stages and under varying environmental contexts. In our preliminary work, a few false positives occasionally led to herbicide applications to weed-free turfgrass. Also, we observed that in situations where weed presence (particularly grassy weeds) in the camera's path exceeded that of turfgrass, the detection system became confused, effectively reversing target and background and treating turfgrass instead of the weed. However, developers are actively addressing these shortcomings and performance of targeted applications systems by continuing to improve imagery databases, training and validation across diverse geographical regions and management contexts. There is no doubt that machine vision-guided sprayers will have a transformative impact on the turfgrass industry, however, extension efforts will be critical for adoption. Also, as this technology is still novel for turfgrass systems, ongoing research and development is critical to improve performance, reliability, and to meet industry needs. Among others, further research is needed to evaluate performance under varying travel speeds, expand applications to targeted residual treatments, and refine application thresholds to maximize herbicide savings. Authors acknowledge the Turfgrass Council of North Carolina for sponsoring ongoing research projects focused on leveraging targeted application devices for weed management in NC turfgrass systems. The authors also thank Ecorobotix Inc. for providing a commercial unit for evaluation. You have been listening to The Turf Zone Podcast. Follow The Turf Zone on X, Facebook and LinkedIn for all things turfgrass, featuring podcasts, magazines, events and more. Visit www.theturfzone.com for more. The post Advancing Precision Weed Management in Turfgrass Systems with Machine Vision-Guided Targeted Spraying appeared first on The Turf Zone.

Host Seth Swerczek and Preston Lentfer continue the budget precision rifle project by breaking down the upgrades made to the Glenfield Model A in 6.5 Creedmoor. From aftermarket parts to setup changes, the duo compares the new dispersion results using the same Hornady ammunition from Part 1 to see whether the upgrades improved performance—or made things worse.

Right now, as you're reading this sentence, something remarkable is happening in your brain. Light waves from your screen hit your eyes, transform into electrical signals, and take on meaning. You understand what you're reading. This is language — our human superpower.But despite 150 years of intensive research, we still do not have a complete picture of how the brain actually accomplishes all of this. We don't even have a good answer to a seemingly simple question: Where in the brain does language happen? It turns out, the answer may be different in different people.Today we'll hear from neuro-linguist Cory Shain, one of the leaders of a new Big Ideas in Neuroscience project here at Wu Tsai Neuro that is combining multiple brain recording techniques to build individualized maps of the language network—and use these insights to improve brain implants for people who've lost the ability to speak or write due to brain injury or illness.Learn moreLaboratory for Computation & Language in Minds & BrainsLaboratory of Speech NeuroscienceNeural Prosthetics Translational LabBrainGateHow the Brain Processes Different Components of Language (Psychology Today, 2024)Big Ideas in Neuroscience tackle brain science of everyday life and more (Wu Tsai Neurosciences Institute, 2026)Study of promising speech-enabling interface offers hope for restoring communication (Stanford Medicine, 2025)The neuroscience of understanding (Stanford Momentum, 2025)Distributed Sensitivity to Syntax and Semantics throughout the Language Network(Journal of Cognitive Neuroscience, 2025)Hierarchical dynamic coding coordinates speech comprehension in the brain(Proceedings of the National Academy of Sciences, 2025)Send us a text!Thanks for listening! If you're enjoying our show, please take a moment to give us a review on your podcast app of choice and share this episode with your friends. That's how we grow as a show and bring the stories of the frontiers of neuroscience to a wider audience.We want to hear from your neurons! Email us at at neuronspodcast@stanford.eduLearn more about the Wu Tsai Neurosciences Institute at Stanford and follow us on Twitter, Facebook, and LinkedIn. 

On this episode of The Bandwich Tapes, I sit down with conductor, composer, and longtime contemporary music advocate Brad Lubman for a wide-ranging conversation about interpretation, rehearsal, composition, and the deeper responsibilities of making music with other people.Brad first came onto my radar through his work conducting Steve Reich's music, but this conversation quickly opened into something much larger. He talks about the way audiences often associate him with Reich's music, while reminding us that he had already built a substantial life in new music long before that connection began. From there, we get into a fascinating discussion about what conductors actually do, and why he resists the idea that great conducting is about imposing personality on a score. For Brad, the work begins with the composer's intentions and the discipline of bringing those intentions to life as clearly and honestly as possible.We also spend time on Brad's path as both a percussionist and a conductor, including how his early love of drums and rock music, and later of orchestral music, shaped the musician he became. He reflects on what percussion taught him about immediacy, time, and gesture, and how those lessons still inform the way he teaches conductors today. His thoughts on rehearsal are especially compelling: the idea that a conductor's role is not to dominate but to create conditions in which musicians can play with confidence, clarity, and artistry.A particularly rewarding part of this conversation centers on Brad's own music, especially his powerful piece Tangents for two pianos and two percussionists. He shares the origin of that work, how it emerged during a moment when he was considering stepping away from composition, and why it marked the beginning of a new phase in his musical language. We also talk about his long association with Steve Reich, Ensemble Signal, and the kinds of life-changing moments that can come from simply doing your work well and being ready when the right people are listening.By the end of the conversation, what comes through most clearly is Brad's seriousness of purpose and his belief in music as a communal act. Whether he is conducting, composing, teaching at the Eastman School of Music, or building programs with Ensemble Signal and major orchestras around the world, he approaches music with precision, humility, and an unwavering sense of service to the score and the people making it.Key TakeawaysBrad Lubman offers a thoughtful distinction between “interpretation” and serving the composer's intentions, arguing that great conducting begins with fidelity to the score rather than ego.He explains why so much of what audiences hear as a conductor's influence is actually shaped in rehearsal, not just in performance.Brad reflects on how his background as a drummer and percussionist sharpened his sense of time, touch, and physical gesture.We talk in depth about his piece Tangents and why that work marked a turning point in his life as a composer.Brad shares how key moments in his career — including his connection to Steve Reich and the New York premiere of City Life — came through preparation, reputation, and musical trust.He discusses the communal nature of orchestral music-making and his belief that an ensemble can model cooperation at the highest level.The conversation concludes with a look at his current work as a teacher, conductor, composer, and advocate for contemporary music worldwide.Music from the EpisodeMusic for 18 Musicians (Pulse) - Steve Reich (Ensemble Signal - Brad Lubman, Conductor)Radio Rewrite (I. Fast) - Steve Reich (Ensemble Signal - Brad Lubman, Conductor)Double Sextet (I. Fast) - Steve Reich (Ensemble Signal - Brad Lubman, Conductor)Tangents - Brad Lubman (Icaras Quartet)About the PodcastThe Bandwich Tapes is my chance to sit down with musicians, composers, songwriters, conductors, and creative artists I admire for honest conversations about craft, collaboration, career, and the deeper ideas that shape their work. It's a show about process, perspective, and the stories behind a life in music.Connect with the ShowEmail: contact@thebandwichtapes.com

Join the waitlist for One of One here!

How much does deburring really affect the quality, reliability, and performance of your parts?In this episode of Race Industry Now, host Joe Castello (WFO Radio) sits down with Nick Prohl, Marketing & Sales at SHAVIV, for an in-depth technical discussion on precision deburring and why it remains one of the most important yet overlooked steps in the manufacturing process.Whether you're machining engine components, fabricating chassis parts, producing aerospace components, building race cars, or operating a machine shop, proper deburring can dramatically improve part fitment, assembly efficiency, safety, durability, and overall product quality.Topics covered include:✅ Deburring fundamentals and best practices✅ How burrs impact quality, reliability, and performance✅ Deburring tools for holes, edges, tubing, and sheet metal✅ High-Speed Steel, Cobalt, Carbide, TiN-Coated, and Diamond blades✅ Countersinking techniques and hole finishing✅ Deburring stainless steel, aluminum, cast iron, plastics, and composites✅ Specialized tools for fabrication and manufacturing environments✅ Improving productivity while maintaining dimensional accuracy✅ Common deburring mistakes and how to avoid themSHAVIV demonstrates several innovative deburring solutions designed to help manufacturers, race teams, engine builders, fabricators, and machine shops achieve cleaner edges, safer parts, and more consistent results.Whether you're working in motorsports, performance automotive, aerospace, industrial manufacturing, CNC machining, or fabrication, this webinar provides valuable insights into a critical finishing process that directly impacts product quality and long-term reliability.

Unlock precision shooting secrets to elevate your hunting and competitive game without breaking the bank. Whether you're experienced or new, this episode shows how competitive shooting enhances skills and decision-making. Dan Bertocchini and Justin Crossley explore how match scenarios mimic real hunting challenges, teaching ethical shot placement and gear refinement. Discover how competition boosts confidence and connects you with a passionate community. Tune in to transform your skills and redefine what's possible in the field. Afterwards discover how Kings Camo is revolutionizing hunting gear with modular systems that fit every hunt. Learn about their innovative XKG layering, lightweight packs, and stealth-enhancing technology. Elevate your hunting experience with insights from Andrew Pooch, head of product at Kings Camo. Talk then shifts towards the other Rokslide.com gear reviews and a recap of the latest Western news. PRSuit Series Kings Camo XKG series Cold Bow Challenge 2026 Howl for Wildlife- Take Action   Check out Rokslide's 2025 Best Gear- https://www.rokslide.com/best-gear-of-2025/   Visit Rokslide's Rokcast Forum to submit questions, request a topic or give feedback. To be a guest on Tipsy Tuesday please send an email to Sam@Rokslide.com   [ Rokcast is powered by onX Hunt. For 20% off, use Promo Code “Rokcast” at onX Hunt here https://www.onxmaps.com/hunt/app]

Join hosts Rick Hogg (founder of War HOGG Tactical and 29-year U.S. Army Special Operations combat veteran) and Mark Kelley (founder of Kelley Defense and U.S. Army combat veteran / law enforcement veteran) on the On The Range Podcast for an in-depth conversation with special guest Buck Holly, CEO and Founder of C&H Precision (CHPWS).   In this episode, Buck Holly shares his journey building C&H Precision from custom precision rifles to becoming a leader in rugged, direct-mount red dot optics, modular adapter plates, slide milling services, and innovative pistol upgrades trusted by competitive shooters, law enforcement, military professionals, and responsible armed citizens. Discover expert insights on choosing the right pistol optics, reliable mounting solutions, real-world durability testing, and the future of tactical gear designed for performance under pressure.   Whether you're looking to upgrade your Glock, Sig, Walther, CZ, or other carry pistol with the best red dot sights and adapter plates on the market, or simply want battle-tested advice from industry leaders, this episode delivers actionable takeaways to help you stay 1% better every day.   Listen/Watch Now and level up your firearms training and gear knowledge!

Editor's note: Download and listen to the audio version below and click here to subscribe to the Today in Manufacturing podcast.The Today in Manufacturing Podcast is brought to you by the editors of Manufacturing.net and Industrial Equipment News (IEN).This week's episode is brought to you by Scientific Cutting Tools (SCT).Working with customers that include NASA, Caterpillar and Johns Hopkins demands a combination of proven and new-age strategies and processes. SCT recently offered a look behind the curtain in detailing how listening to their customers and paying attention to key industry trends has established a legacy of innovative problem-solving and an undeniable focus on cutting edge production and product technologies.These same principles have kept the company competitive for more than 60 years in an increasingly crowded marketplace, and led to internal practices focused on attracting new talent while simultaneously retaining vital experience.To learn more about their secrets to long-term success, download this behind-the-scenes report, "Built on Precision, Grounded in Integrity," right now.Every week, we cover the three biggest stories in manufacturing, and the implications they have on the industry moving forward. This week:- Missing Sticker Triggers Recall for Thousands of Teslas- North Carolina Sues Vietnamese EV Maker After Ongoing Delays- SendCutSend Raises $110 Million to Build 'Anything Factories'In Case You Missed It- Robot With 20 Legs and Eyes Built to Move, See in Any Direction Instantly- Blue Origin's $600 Million Expansion Project to Boost Upper-Stage Production in Florida- Slate Auto Nabs Michigan Grant to Expand EV HQPlease make sure to like, subscribe and share the podcast. And to email the podcast, you can reach any of us at Jeff, Anna or David@ien.com, with “Email the Podcast” in the subject line. Subscribe to our daily and weekly newsletters.

In this episode of Precision and Progress: Radiotherapy in Oncology, hosts Hirsch Matani, MD, and Elizabeth Zhang-Velten, MD, PhD, welcomed Binh T. Ngo, MD, to discuss the evolving role of radiation, systemic therapy, and multidisciplinary care for patients with melanoma and other skin cancers.Dr Matani is a clinical assistant professor of radiation oncology at the Keck School of Medicine of the University of Southern California (USC) and a radiation oncologist at the USC Norris Comprehensive Cancer Center. Dr Zhang-Velten is a radiation oncologist and a clinical assistant professor with Keck Medicine of USC. Dr Ngo is an assistant professor of dermatology at Keck Medicine of USC.In their discussion, Drs Matani, Zhang-Velten, and Ngo broke down how surgical approaches, radiation, and systemic therapy all play roles in the treatment of patients with skin cancer. Dr Ngo highlighted key prevention strategies that patients should be advised on, along with recommended follow-ups for patients who are at higher risk or those who underwent prior solid organ or hematologic transplants.The trio also discussed how the use of radiation for patients with skin cancer varies from techniques used for patients with tumors located within deeper organs, and they also highlighted how radiotherapy approaches could be applied for patients with tumors that would be difficult to surgically resect.

Ep 119: Another episode live from the ISA International Sign Expo 2026. Tyler is joined this time by Stuart Fox from Kongsberg to talk precision cutting and routing with Kongsberg and Multicam.Check out the featured products:SIHL ProductsGFP ProductsArlon DPF V9500G2G Products"Your podcast is the best podcast in the business." - Jared Granberry, President, GSG (Graphic Solutions Group)The Slightly Serious Sign Podcast is now the #1 Most Fact Checked Podcast in the United States.Voted #1 by Signman (standing on a van on top of 18 pallets changing a lightbulb over a movie theater sign)https://www.wensco.com/company/slightly-serious-sign-podcast616.785.3333W.A.R. (Wensco Automotive Restyling)Slightly Serious Sign Podcast Theme Song Courtesy of Joe Morreale© 2025 Joe MorrealeThe views, thoughts, and opinions expressed are the speaker's own and do not represent the views, thoughts, and opinions of Wensco Sign Supply. The material and information presented here is for general information purposes only. The "Wensco Sign Supply" name and all forms and abbreviations are the property of its owner and its use does not imply endorsement of or opposition to any specific organization, product, or service. Things to...

This week we talk about: Zoho CRM: Old UI Retires July 15 Zoho Bigin: AI Features Come to the Web App Zoho Payments: Manage Payment Links, Refunds, and Payouts with MCP Our Code Share, Read, Tip and Question of the Week Read the show notes: https://zenatta.com/episode-408/    ⚖️ Avalara AvaTax for Zoho CRM ⚖️ Accurate Tax. Zero Guesswork.

Artificial intelligence is rapidly reshaping the landscape of rare disease research -- but how close are we to realizing its full potential? In this episode, Tanya Binette (Director of Therapeutic Expertise, Rare Disease at ICON plc) and Roz Round (SVP of Operational Strategy, Patient and Site Engagement at Precision for Medicine) explore how AI is being applied across the rare disease clinical trial lifecycle, from drug discovery and protocol design to patient identification and engagement.The discussion highlights both the promise and complexity of using AI in a research space defined by small patient populations, fragmented data, and unique ethical considerations. Guests emphasize the importance of patient trust, regulatory alignment, and responsible innovation, while also identifying opportunities to accelerate trials, improve access, and empower patients through AI-enabled tools.

China has launched a nationwide campaign to establish records for migrant and left-behind children, aiming to enhance the precision of welfare services.

Hell yeah! Nothing says it's summertime like an atmospheric firehose! Hope you had a grand Memorial Weekend and that you let Bret Michaels honor the fallen in peace. Now let's party! NYC hosts half of the top 50 pizza spots in America and holds court in the top 5 spots in the entire world. Now in Charlotte, Keith skips Cook Out to try out America's 41st best: Pizza Baby. Keith also reviews entertainment juggernauts Star Wars: The Mandalorian & Yoda and The Boys series finale. He also dives into AI, featuring: ChatGPT making an animation based on Keith's new book, revisiting Keith trying to get Grok to speak to him as an apologetic ex, and Taxi Driver screenwriter Paul Schrader telling us that his AI girlfriend broke up with him. AD: This episode is brought to you by the new Shit Number smart toilet. “Precision analytics for your daily business.”

Power plant water and steam chemistry does not fail in isolation. A mistaken unit, an unused analyzer, an overdesigned pretreatment system, or a misunderstood condensate return problem can ripple across equipment, permits, production, and safety. In this Part 2 conversation with Bradley Buecker of SAMCO Technologies and Buecker Associates, Trace Blackmore continues a practical discussion on the details that shape industrial water decisions. Brad shares field stories from combined cycle plants, package boilers, wastewater permitting, membrane systems, and decades of technical writing.   When Small Errors Become Expensive Problems Brad opens with a story about a wastewater permitting issue where parts per million and parts per billion were confused in a discharge permit. The result was not just a paperwork problem. Once the stricter limits were accepted by regulators, meeting those limits would have required more complex and expensive wastewater treatment equipment. That story is a reminder for water professionals reviewing RFPs, permits, and engineering specifications. Precision matters before a project is built, not after the limits have already been approved. Brad also discusses PFAS with appropriate caution. He does not present himself as a PFAS expert, but he connects the conversation to zero liquid discharge, brine concentrators, crystallizers, and the unresolved question of what happens to solids when contaminants are concentrated rather than discharged.   Membranes, Discharge, and the Changing Water Balance Looking across more than four decades in the industry, Brad points to membranes as one of the major changes in power plant water treatment. He discusses how reverse osmosis extended ion exchange demineralizer run times, and how microfiltration and ultrafiltration improved water quality going to RO systems. However, Brad also makes clear that better pretreatment does not remove every operational question. RO reject remains a substantial discharge stream. Meanwhile, the movement away from once-through cooling toward cooling towers has changed how plants think about water consumption, evaporation, discharge, and resource availability. For professionals managing water in power and industrial systems, the episode reinforces a practical lesson: every improvement has a system-level consequence that must be understood.   The Real Cost of "Lean and Mean" Brad uses the phrase "lean and mean" to describe how some combined cycle plants are staffed. In one example, a plant had a comprehensive online chemistry monitoring system installed, but it had never been turned on because the staff did not have the experience to maintain or interpret it. In another case, a groundwater-based makeup system included seven-layer multimedia filters even though groundwater typically has very few particulates. Brad could not make a categorical conclusion without a full analysis, but the story raises an important question: are we solving the actual water problem, or simply buying equipment? He also shares a case from an organic chemicals plant with four 550 PSI package boilers. The plant returned 80 to 90 percent of its condensate, but total organic carbon levels were far above the ASME recommended limit for that pressure boiler. Foam in the saturated steam samples helped point to carryover into the superheaters, where scale was building up inside the tubes.   Learning, Mentorship, and Leaving the Industry Better Beyond the technical stories, Brad's message is clear: professionals who keep learning are better prepared to make sound decisions. He encourages newer water treaters to study strong water treatment handbooks, talk to experienced people, and physically connect chemistry data to the equipment and processes in the plant. For those nearing retirement, Brad offers a different kind of challenge: pass along what you know while there is still time. He and Trace discuss how sharing experience strengthens the next generation instead of threatening the people who already hold knowledge. The episode closes with a reminder that water is central to manufacturing, power generation, and daily life. Keeping the lights on and protecting water resources both require people who understand the systems behind the scenes. Listen to the full conversation above. Explore related episodes below. Stay engaged, keep learning, and continue scaling up your knowledge!   Timestamps  02:16 — Trace introduces Part 2 of his conversation with Bradley Buecker and sets up the continuation of a technical discussion on power plant water and steam chemistry. 04:10 — Trace asks Brad about a case where an engineering firm confused parts per million and parts per billion in wastewater permitting. 05:38 — Brad explains how NPDES discharge permits shape what a new plant must control before construction and operation. 06:35 — Brad describes how some constituents with typical PPM limits were submitted as PPB, creating a much stricter compliance problem. 07:18 — Brad explains why trying to meet unnecessarily low PPB limits can require exotic wastewater treatment equipment. 07:51 — Trace pivots the conversation to PFAS, and Brad responds carefully by acknowledging the importance of the issue while noting that he is not a PFAS expert. 08:34 — Brad connects PFAS concerns to zero liquid discharge, brine concentrators, crystallizers, and the question of what happens to concentrated solids. 11:27 — Brad identifies membranes as one of the major industry changes he has seen across more than four decades. 11:44 — Brad explains how RO systems placed ahead of ion exchange demineralizers extended operating run times in power plant makeup water treatment. 12:35 — Brad notes that membrane systems still create discharge challenges, including substantial RO reject streams. 13:23 — Brad discusses the shift away from once-through cooling and how cooling towers changed the water consumption picture for power plants. 16:14 — Trace asks Brad about the phrase "lean and mean," opening a discussion about staffing, expertise, and hidden operational risk. 17:25 — Brad shares a case where a comprehensive online chemistry monitoring system had never been turned on because the plant lacked the right technical support. 18:31 — Brad describes a groundwater-based makeup system with a seven-layer multimedia filtration setup and raises the question of whether the equipment fit the actual water source. 20:39 — Brad introduces a case involving four 550 PSI package boilers at an organic chemicals plant producing superheated steam for process use. 21:30 — Brad explains that 80 to 90 percent condensate return, high TOC readings, and foaming in saturated steam samples pointed toward carryover into the superheaters. 23:29 — Brad summarizes the risk of cutting too deeply: being lean and mean can cost more in the long run. 23:55 — Brad reflects on the importance of continuous learning and shares his regret about not pursuing a master's program in environmental science. 25:19 — Trace shares his father's advice to leave the industry better than he found it, and Brad connects that idea to sharing safety-critical knowledge. 29:25 — Brad advises newer professionals to learn the basics, study reliable water treatment handbooks, and connect lab work to real plant systems. 35:32 — Brad thanks retiring professionals and encourages them to pass along practical knowledge to younger people while they still have time. 37:23 — Brad explains what people outside the industry should understand about water's role in manufacturing, power generation, and daily life.   Quotes  "Those are very important because if something goes south chemistry-wise at a power plant, you need to know very quickly." "You can be lean and mean, but it can cost you a lot more in the long run." "If you have any ambition or interest at all, continue learning." "If you pass along your information and give younger people a chance to do something, give them some responsibility, it just pays off much more."   Connect with Bradley Buecker  Email: bueckerb@samcotech.com   LinkedIn: https://www.linkedin.com/in/bradley-buecker-705b9021/  Website: Water & Wastewater Treatment Solutions | SAMCO Technologies   Guest Resources Mentioned   US EPA - National Pollutant Discharge Elimination System (NPDES)  Buecker & Associates, LLC - Consulting and Technical Writing  Beware of Flow-Accelerated Corrosion – Brad Buecker, Kiewit Engineering Group  Muck Rack – Brad Buecker Articles    Scaling UP! H2O Resources Mentioned  AWT (Association of Water Technologies)  Scaling UP! H2O Academy video courses  Submit a Show Idea  The Rising Tide Mastermind  477 Rethinking Power Plant Water and Steam Chemistry with Brad Buecker (Part 1)    Words of Water with James McDonald Today's definition is the standard SI unit for the amount of substance, defined exactly as 6.02214076 x 10^23 elementary entities, such as atoms or molecules.  Can you guess the word or phrase?    2026 Events for Water Professionals  Check out our Scaling UP! H2O Events Calendar where we've listed every event Water Treaters should be aware of by clicking HERE.     

We love to hear from our listeners. Send us a message.This is Episode 1 of a four-episode in vivo-focused special series of Cell & Gene: The Podcast. Host Erin Harris speaks with Cassie Gorsuch, Ph.D., CSO at Precision Biosciences, about the rapid evolution of in vivo gene editing and the scientific, translational, and regulatory hurdles shaping the field. Dr. Gorsuch discusses how Precision Biosciences approaches in vivo therapeutic development through its Arcus platform, with programs targeting chronic hepatitis B and Duchenne muscular dystrophy. They cover the broader challenges facing in vivo gene editing, including delivery limitations outside the liver, balancing specificity and efficiency, mitigating off-target risks, and translating promising preclinical in vivo data into clinical success.Subscribe to the podcast!Apple  |  Spotify |  YouTubeVisit my website: Cell & GeneConnect with me on LinkedIn

What is precision medicine, and how should precision medicine be handled in the face of guidelines and protocols? In this episode of the Society of Critical Care Medicine (SCCM) Podcast, Diane C. McLaughlin, DNP, AGACNP-BC, CCRN, FCCM, speaks with Michael R. Pinsky, MD, FAPS, MCCM, about his Thought Leader presentation at the 2026 Critical Care Congress, The Effective Management of Shock: Moving From Physiology to Guidelines to Precision Medicine and Ultimately Personalized Medicine. The panel also discusses how to titrate care for individual patients. Protocols and guidelines are the foundation for patient care and are instrumental for having all healthcare professionals on the same baseline when treating patients. Precision medicine involves individualizing care for a specific patient, and Dr. Pinsky emphasizes that guidelines should never supersede an understanding of pathophysiology at the bedside, including observing your patient and paying attention to how individual patients respond to specific treatments. Monitoring the individualized response is required for the best care. Michael R. Pinsky, MD, FAPS, MCCM, is a professor of critical care medicine, bioengineering, and anesthesiology at the University of Pittsburgh in Pittsburgh, Pennsylvania, USA. He is also Docteur Honoris Casusa at the Université René Descartes Paris V School of Medicine in Paris, France. In 2012, he became one of the first 20 critical care physicians to receive a Master of Critical Care Medicine (MCCM) from SCCM. He is currently an emeritus (honorary) at UPMC. At the University of Pittsburgh, he is vice-chair emeritus for the Department of Critical Care Medicine and a faculty member at the Center for Critical Care Nephrology and the Center for Military Medicine Research. Resources referenced in this podcast: The Effective Management of Shock: Moving From Physiology to Guidelines to Personalized Medicine

Host Seth Swerczek and Preston Lentfer put a bone-stock Glenfield Model A in 6.5 Creedmoor to the test to see just how much precision you can get on a budget. From the scope, rings, and bipod setup to testing three varieties of Hornady ammunition, the duo establishes a baseline for the rifle's dispersion capability before diving into upgrades. Stay tuned for Part 2, where aftermarket modifications are added to see if the improvements make a difference.

When it comes to treating chronic sinus disease with nasal polyps…what's the best approach, surgery or biologics?Well, the answer is it's usually not either-or anymore.When patients are trying to manage these challenging conditions, some people opt for one or the other. But more physicians are finding that surgery and biologics aren't different paths. They are actually treatment protocols that complement each other.Surgery may remove the growths, but it doesn't necessarily stop the process of creating them in the first place. Biologics may suppress the inflammatory pathways driving recurrence, but they don't physically restore blocked sinus anatomy or remove bulky disease.We're entering a new phase of care where the question is no longer “surgery or biologics?” but how both can work together as part of a personalized strategy.Instead of treating every patient the same way, physicians are now looking deeper at the inflammatory pathways driving disease, recurrence risk, quality of life, and even how different biologics target different parts of the immune cascade.The shift is moving chronic sinus care away from a one-size-fits-all model and toward precision medicine that's designed around the individual patient.In this episode, I'm joined by Dr. Tassos Hantzakos, staff physician in otolaryngology and residency program director at Cleveland Clinic Abu Dhabi, and Dr. Deepa Sheth, allergy and immunology specialist.Together, we break down how the treatment landscape for chronic rhinosinusitis with nasal polyps is evolving, why collaboration between ENT and allergy specialists is becoming essential, and how biologics are reshaping the future of inflammatory airway disease management.Things You'll Learn In This Episode Not just a surgical problemFor decades, treatment focused on physically removing nasal polyps, but many patients still experienced recurrence. Why does surgery alone often fail to stop the disease?Biologics are changing how we think about airway diseaseNew biologic therapies are targeting different parts of the inflammatory cascade. How do physicians decide which biologic is the best fit for a specific patient?The future of treatment is collaborative, not competitiveThe conversation is shifting away from “surgery versus biologics” toward integrated care between ENT surgeons and allergists. When should surgery come first, and when should biologics be introduced?Precision medicine is reshaping chronic inflammatory careDifferent patients may require different treatment approaches. How does identifying the root inflammatory driver completely change long-term management outcomes?Guest BioDr. Tassos Hantzakos is a staff physician in the Otolaryngology Department at Cleveland Clinic Abu Dhabi's Integrated Surgical Institute, where he also serves as Program Director of the Otolaryngology Residency. His clinical expertise spans otolaryngology, rhinology, phonosurgery, laryngeal laser surgery, and voice disorders. Before joining Cleveland Clinic Abu Dhabi, Dr. Hantzakos served as a consultant within the Hellenic National Health System, Director of the Voice Clinic at NUKA, and Clinical Associate Professor at Cleveland Clinic Lerner College of Medicine in the US. He has contributed to numerous international journal articles and textbooks and is actively involved in several professional societies, including the European Laryngological Society, the International Association of Phonosurgeons, the Voice Foundation, and the European Society for Swallowing Disorders. Outside of medicine, he enjoys spending time with his family, long-distance running, triathlons, and playing guitar and drums. Connect with him on LinkedIn. Dr. Dipa K. Sheth is an allergist-immunologist based in Washington, DC, and an Assistant Professor of Medicine at Uniformed Services University of the Health Sciences. Her clinical work focuses on allergy and immunology, with experience treating conditions such as chronic sinusitis, rhinitis, atopic dermatitis, drug hypersensitivity, and food hypersensitivity. Dr. Sheth received her medical degree and completed her internal medicine training at George Washington University, followed by a fellowship in Allergy and Immunology at the University of Colorado School of Medicine and National Jewish Health. Her research has been published in journals including Frontiers in Allergy and Current Opinion in Allergy and Clinical Immunology. Connect with her on LinkedIn. About Your HostHosted by Dr. Deepa Grandon, MD, MBA, a triple board-certified physician with over 23 years of experience working as a Physician Consultant for influential organizations worldwide. Dr. Grandon is the founder of Transformational Life Consulting (TLC) and an outspoken faith-based leader in evidence-based lifestyle medicine.Disclaimer ​​TLC is presenting this podcast as a form of information sharing only. It is not medical advice or intended to replace the judgment of a licensed physician. TLC is not responsible for any claims related to procedures, professionals, products, or methods discussed in the podcast, and it does not approve or endorse any products, professionals, services, or methods that might be referenced.Work With Me Learn More About My Soon-to-Launch Telemedicine PlatformExciting news. My virtual medical platform is launching soon! If you're looking for personalized, evidence-based care in allergy, immunology, and lifestyle medicine, stay tuned. Visit drdeepa-tlc.org and click on “Learn More” to join the waitlist and be the first to receive updates about services, membership options, and launch details.Precision care. Personalized guidance. Wherever you are.Devotionals Want to receive a devotional every week from Dr. Deepa? Devotionals are dedicated to providing you with a moment of reflection, inspiration, and spiritual growth each week, delivered right to your inbox. Visit drdeepa-tlc.org to subscribe for free.Trauma Courses Ready to deepen your understanding of trauma and kick-start your healing journey? Explore a range of online and onsite courses designed to equip you with practical and affordable tools. From counselors, ministry leaders, and educators to couples, parents, and individuals seeking help for themselves, there's a powerful course for everyone. Browse all the courses now to start your journey.

Why are some drivers fast in everything? What makes a person quick in Miatas but not Mustangs—or vice versa? How do the pros wrap their heads around big jumps in speed, power, and risk?This is show about many things. Precision. Restraint. A Corvette Z06 walloping into the climbing esses at VIR. That feeling you get when everything is right and nothing is wrong, at least not anything important, and you are up on the tire and the sky is awash in blue.“Being shot out of a cannon will always be better than being squeezed out of a tube.”This show changes format every episode, because squirrel. This format is a new one—we call it ROSS AND SAM DISSECT THE OBVIOUS.***This episode was produced by Sam Smith. As always, thanks to our friends at BFGoodrich for supporting the show!**Who We Are + Spicy Merch:⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.ItsNotTheCar.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠**Support It's Not the Car:Contribute on Patreon ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.patreon.com/notthecar⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠**Topic suggestions, feedback, questions? Let us know what you think!⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠INTCPod@gmail.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠**Check out Sam's book!⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Smithology: Thoughts, Travels, and Semi-Plausible Car Writing, 2003–2023⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠**Where to find us:⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/intcpod⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/thatsamsmith/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/j.v.braun/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/rossbentley/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://rossbentley.substack.com/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://speedsecrets.com/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠**ABOUT THE SHOW:It's Not the Car is a podcast about people and speed. We tell racing stories and leave out the boring parts.Ross Bentley is a former IndyCar driver, a bestselling author, and a world-renowned performance coach. Jeff Braun is a champion race engineer. Sam Smith is an award-winning writer and a former executive editor of Road & Track magazine.We don't love racing for the nuts and bolts—we love it for what it asks of the meatbag at the wheel.New episodes biweekly on Tuesdays.

In this episode, Justine Reichman interviews Stacey Berger, a seasoned product developer and founder of Sum Of All, about her journey into creating precision skincare tailored for women in midlife. They explore the science behind hormonal skin changes, sustainable beauty practices, and the importance of intentional product formulation. Keywords skincare, menopause, sustainability, women in midlife, product development, hormonal skin, clean beauty, innovation, self-care, empowerment Key  topics Hormonal impact on skin during menopause The importance of science-backed ingredients Sustainable and clean beauty practices Building a brand with purpose and intention The role of collaboration with medical experts Chapters 00:00 Introduction to Essential Ingredients and Guest Introduction 01:42 Stacey's Journey in Product Development 03:47 The Transition to Entrepreneurship 06:29 Overcoming Challenges as an Entrepreneur 09:00 The Importance of Community and Support 13:31 Personal Experience with Perimenopause 16:40 Identifying the Market Gap 22:10 Precision Skincare Explained 29:28 The Intent Behind Clean Beauty 32:35 Navigating Clean and Sustainable Choices 34:53 Empowering Women Through Beauty 39:24 Sustainability Challenges in Product Development 40:44 Holistic Approach to Beauty and Wellness 42:28 The Role of Indie Brands in Beauty Innovation 44:24 Customer Impact Stories 49:16 Reassurance for Women in Midlife 51:04 Rapid Fire Insights on Beauty Guest links Instagram - https://www.instagram.com/some_of_all_beauty

Michael talks with Admiral James Stavridis about escalating tensions with Iran, the reopening of the Strait of Hormuz, and the future of AI-assisted warfare. Prompted by Pope Leo's warning about autonomous weapons, Michael asks whether artificial intelligence will ultimately make war more precise and humane—or easier to wage. Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.

Join us in this episode as Dr. Adrijana Kekic, Founder and CEO of Futurome, discusses her approach to helping leaders, executives, and high performers extend both lifespan and healthspan using science-backed precision tools.  Futurome is a concierge longevity company specializing in precision medicine for high performers. As a longevity pharmacist and expert in systems biology, Dr. Kekic uses multiomics, digital biomarkers, and AI-driven tools to create personalized healthspan strategies… Hit play to discover: What multiomics are and how they can be used to optimize health. What to do when blood tests keep coming back normal despite ongoing symptoms. How pharmacogenomics can predict what a medication actually does for you. The benefits of simulating future health before problems develop. What cellular drift is and how to detect it early. You can connect with Dr. Kekic at Futurome.com, Instagram, LinkedIn, and Youtube!

Join Chad Hyams and Bob Stewart as they sit down with Mark Roberge, former sales leader at HubSpot and author of "The Science of Scaling." Delve into the nuances of effective selling, understanding customer value, and the art of scaling businesses using data-driven strategies. Roberge shares insights on the importance of customer retention metrics, social selling, and the evolving landscape of tech startups. Perfect for entrepreneurs eager to refine their approach and maximize growth while maintaining meaningful customer relations. Discover actionable strategies in sales and scaling, blended with personal insights on mental health. ---------- Connect with the hosts: •    Ben Kinney: https://www.BenKinney.com/ •    Bob Stewart: https://www.linkedin.com/in/activebob •    Chad Hyams: https://ChadHyams.com/ •    Book one of our co-hosts for your next event: https://WinMakeGive.com/speakers/   More ways to connect: •    Join our Facebook group at www.facebook.com/groups/winmakegive •     Sign up for our weekly newsletter: https://WinMakeGive.com/sign-up •     Explore the Win Make Give Podcast Network: https://WinMakeGive.com/   Part of the Win Make Give Podcast Network 00:00 Navigating Work Events, Disneyland, and Guest Introductions 04:28 Teaching Sales and Entrepreneurship at Harvard Business School 09:21 The Evolution and Strategy of Effective Social Selling 14:01 Identifying Retention Indicators for Business Growth 20:15 Scaling Businesses Through Strategic Growth and Profitability 23:51 Discovering Unique Value Through Customer Interaction and Feedback 30:51 Mental Health Advocacy Through Book Proceeds and Tech Evolution 34:48 Avoiding Common Pitfalls When Scaling a Business